Tempest Therapeutics, Inc. (TPST)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 5 signals for Tempest Therapeutics, Inc.. Most notable: 2026-08-24: Filed 8-K disclosing director or officer change; 2026-07-22: Filed 8-K disclosing material agreement; 2026-08-13: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing material agreement
  5. Material 8-K filing
    Filed 8-K disclosing material agreement
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change
  7. Material 8-K filing
    Filed 8-K disclosing material agreement
  8. Material 8-K filing
    Filed 8-K disclosing director or officer change
  9. Material 8-K filing
    Filed 8-K disclosing director or officer change
  10. Insider purchase
    Angel Matthew (director) bought $500k of stock
  11. Insider purchase
    Angel Matthew (director) bought $500k of stock
  12. Material 8-K filing
    Filed 8-K disclosing material agreement
  13. Material 8-K filing
    Filed 8-K disclosing material agreement, acquisition or disposition of assets, director or officer change
  14. Material 8-K filing
    Filed 8-K disclosing director or officer change
  15. Material 8-K filing
    Filed 8-K disclosing material agreement, director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-03-24Angel MatthewdirectorP231,4822.16$500,001
2026-03-24Angel MatthewdirectorP231,4822.16$500,001
2024-08-12Versant Venture Capital VI, L.P.ten percent ownerS387,9991.1$426,799
2024-08-08Versant Venture Capital VI, L.P.ten percent ownerS400,0001.35$540,000
2024-07-03Brady Stephen RdirectorP35,0002.11$73,850
2024-07-02Whiting SamuelofficerP4,6722.13$9,951
2024-06-28Trojanowski JustinofficerP7,5002.16$16,200

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

Tempest Therapeutics, Inc. (TPST): insider trades, federal contracts, lobbying | IP Files